Sage Therapeutics Inc. (SAGE)
7.15
-0.05 (-0.69%)
At close: Mar 04, 2025, 9:55 AM
Sage Therapeutics Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -400.67M | -541.49M | -532.78M | -457.89M | 606.07M | -680.24M | -372.88M | -270.12M | -158.99M | -94.5M | -33.81M | -18.28M | -9.63M |
| Depreciation & Amortization | -5.45M | 1.39M | 1.12M | 4.18M | 2.63M | 2.28M | 1.14M | 531K | 281K | 115K | 51K | 47K | 44K |
| Stock-Based Compensation | 54.5M | 73.37M | 61.6M | 104.63M | 95.99M | 153.23M | 101.96M | 35.53M | 23.02M | 15.24M | 2.51M | 61K | n/a |
| Other Working Capital | 8.51M | -58.89M | -2.76M | -6.69M | -28.22M | 25.44M | -5.33M | 18.87M | 9.68M | 4.56M | 3.64M | -81K | 53K |
| Other Non-Cash Items | -344K | -6.47M | 4.35M | -10.6M | -688K | -10.64M | -10.11M | -398K | -470K | 1.21M | 127K | 64K | 662K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 84.76M | -67.38M | 5.67M | -18.51M | -39.73M | 6.66M | 19.21M | 15.18M | 17.48M | 7.25M | 4.08M | 593K | 662K |
| Operating Cash Flow | -267.19M | -540.59M | -460.04M | -378.18M | 664.28M | -528.71M | -260.67M | -219.28M | -118.68M | -70.68M | -27.04M | -17.52M | -8.93M |
| Capital Expenditures | n/a | -553K | -937K | -372K | -345K | -5.75M | -2.86M | -1.36M | -1.42M | -198K | -128K | -3K | -111K |
| Acquisitions | n/a | n/a | -326.37M | 1B | -443.03M | 137.41M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -450.96M | -594.67M | -881.04M | -1.99B | -458.72M | -1.31B | -1.48B | -244.4M | -259.09M | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 717.63M | 1.04B | 1.21B | 988.08M | 901.75M | 1.17B | 974.76M | 261.23M | 30.5M | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | 326.37M | -1B | 443.03M | -137.41M | -509.6M | -285K | -525K | n/a | n/a | n/a | n/a |
| Investing Cash Flow | 266.68M | 442.91M | 325.43M | -1B | 442.68M | -143.16M | -512.46M | 15.18M | -230.54M | -198K | -128K | -3K | -111K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | -903K | -43K | -1.39M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 2.5M | 6.03M | 3.07M | 13.33M | 9.26M | 46.35M | 27.86M | 15.79M | 807K | 146K | 50.62M | 22.73M | 8.99M |
| Financial Cash Flow | 10.66M | 6.03M | 3.07M | 13.33M | 426.76M | 607.62M | 659.36M | 341.82M | 330.98M | 129.87M | 146.87M | 22.78M | 9M |
| Net Cash Flow | 10.15M | -91.64M | -131.53M | -1.37B | 1.53B | -64.24M | -113.77M | 137.72M | -18.24M | 58.99M | 119.7M | 5.26M | -40K |
| Free Cash Flow | -267.19M | -541.14M | -460.97M | -378.55M | 663.93M | -534.46M | -263.53M | -220.64M | -120.1M | -70.88M | -27.17M | -17.52M | -9.04M |